Clinical implications of renin–angiotensin system inhibitors for development and progression of non-alcoholic fatty liver disease

Clinical implications of renin–angiotensin system inhibitors for development and progression of non-alcoholic fatty liver disease

Abstract Recently, there has been an increasing interest in the therapeutic efficacy of RAS inhibitors (RASi) in patients with non-alcoholic fatty liver disease (NAFLD) because they may reduce oxidative stress, inflammatory markers, and enhanced fibrosis. An objective of this study was to investigat...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kwang Min Kim, Ji-Hye Roh, Sangjin Lee, Jeong-Hyun Yoon
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/648294fd0b844a61a38cb4f6b5afa69b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares